当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Murray Grossan
Mucociliary Clearance can be measured clinically with the Saccharine Test in the sino-nasal system. When clearance is slow, treat mucus viscosity and slow ciliary beat frequency. Chronic sinusitis and bronchitis are often due to poor MCC. Therapy to upper or lower respiratory system benefits both. Therapy for Mucociliary Clearance includes proteolytic enzymes to reduce mucus viscosity, vibrations for improving ciliary beat frequency, irrigation with Locke-Ringer's solution for cilia frequency, glucosteroids and surfactants. Use of the Saccharine Test can help determine toxic effects of chromium, Sulphur Dioxide, benzines and other toxic products. In acute allergy, mucociliary clearance speeds up; but sinusitis may follow when mucociliary clearnace slows down later. In slow mucociliary clearance, bacteria remain in place and are able to multiply. This is a significant factor for recurrent sinus infections and indicates a method of treatment that includes restoring normal mucociliary clearance (MCC). Measuring MCC in the lower respiratory tract is complex and includes inhalation of radioactive particles. Clinically, the results of the Saccharine test of the nasal system may be an indicator of the MCC in the lower respiratory system.